• Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to primary sidebar

Before Header

Link Medical Research

CRO – Contract Research Organization

  • Home
  • Solutions
    • Early Development
    • Clinical Development
    • Post-Marketing
    • LINK Advantage
    • Market Access & RWE
    • Medical Device
    • Medical Experts
    • Medical Writing
    • Pharmacovigilance
    • Clinical Operations
    • Project Management
    • Quality Assurance
    • Regulatory Affairs
    • Marketing Compliance
    • Biometrics
    • Other Services
  • Therapeutic areas
  • About Us
    • Our Management
    • How We Work
    • Case Studies
    • Customer Testimonials
    • Our Memberships
  • News & Events
    • News
    • Events
    • Publications
    • Videos
  • Contact
  • Careers
    • Our Careers
    • Jobs
    • LINK Team Testimonials
  • Search
  • Home
  • Solutions
    • Early Development
    • Clinical Development
    • Post-Marketing
    • LINK Advantage
    • Market Access & RWE
    • Medical Device
    • Medical Experts
    • Medical Writing
    • Pharmacovigilance
    • Clinical Operations
    • Project Management
    • Quality Assurance
    • Regulatory Affairs
    • Marketing Compliance
    • Biometrics
    • Other Services
  • Therapeutic areas
  • About Us
    • Our Management
    • How We Work
    • Case Studies
    • Customer Testimonials
    • Our Memberships
  • News & Events
    • News
    • Events
    • Publications
    • Videos
  • Contact
  • Careers
    • Our Careers
    • Jobs
    • LINK Team Testimonials
  • Search

Top Content

Market Access & Real World Evidence (RWE)
Home / Solutions / Market Access & Real World Evidence (RWE)

Market Access & Real World Evidence (RWE)

Reducing risk with Health Economics (HE)

On the route to market, pharmaceutical or medical device products must reach many challenging milestones before the first patients will benefit from its therapeutic use and it becomes regularly reimbursed. For this reason, companies and their investors need to mitigate risk with accurate cost estimates on the specific stages of the market access process. Through a strategic partnership with LINK Medical, you will have access to our highly competent team that can help you accomplish this challenging task. We communicate actively with our customers to understand their business needs, and employ a variety of health economic tools and methods to provide full-service support throughout product development.

Getting the process right with Early Benefit Assessments

We utilize a variety of rigorous analytical methods for early assessments of pharmaceutical and medical device products, and keep them up-to-date as development progresses. To achieve this, we work in close collaboration with you to define the development phases of the regulatory and reimbursement strategies, as well as the milestones for allocating funding support. When bringing a new product to market, medical technology companies must present models of cost-effectiveness, cost-utility and cost-benefit to compare their products to standard treatments and devices on the market. Our uniquely talented staff have the deep understanding and experience to develop impactful health economic models that will support your entry into the market.

Creating market success

Obtaining reimbursement can often be a long-term project and success depends on various terms and regulations. Our experts can advise and guide you through the opportunities and potential risks of different reimbursement strategies. Our key local knowledge of markets across Northern Europe ensures that the reimbursement applications we produce adhere to all requirements and submission deadlines of local health authorities. Our team is highly experienced in the execution of every required step before launching a new commercial operation.

The value of Real World Evidence (RWE)

Real World Evidence (RWE) is an increasingly crucial component of benefit, risk and value demonstration, particularly for cases where the collection of data via traditional routes is difficult. These challenging studies can involve innovative medical device products, advanced medicinal therapies, or treatments for orphan and rare diseases. Our RWE services accelerate clinical development by providing indication prioritization along with faster and smaller randomized control trials (RCTs). Our iterative approach to evidence generation and early value proposition will ensure that your product reaches the market as soon as possible. In the post-marketing stage, we offer life cycle management services that maximize the value of your product after loss of exclusivity.

To find out more about how effective use of RWE and HE analyses can accelerate your product development, contact our Head of Department, Beate Bjørnstad Løkke at beate.lokke@linkmedical.eu.

Overview of RWE and HE services:

  • Reimbursement applications for pharmaceutical products and medical devices
  • Health Economic models
  • Budget impact models
  • Burden of illness studies
  • Guidance on market access environment
  • Real World Evidence and registry studies
  • HTA/STA assessment and appraisal
  • Literature reviews

Head of Department

Beate Bjørnstad Løkke,
Director Market Access

Beate is the Director for our Market Access team, she has 5+ years of health economics (HE), market access (MA) and real world evidence (RWE) experience, covering therapeutic areas such as oncology, neurology, and immunology. She has hands on experience in Project management in HE, MA, and RWE projects, as well as strategic market access, advice within pharmaceuticals and medical device product life-cycle in addition to experience with developing health economic models.

Beate Løkke, holds a master of Health Economics, Policy and Management (Mphil) from the University of Oslo, with specialization within economic evaluation.
​
Contact via email

Related links

  • Case Study: Exploring market access of a medical device with health economic modelling
Systematic literature review
A systematic literature review (SLR) is required by the Norwegian Medicines Agency (NoMA) when submitting a reimbursement application. This is also required for medical devices. Additionally, a SLR is crucial in the development of Global Value Dossiers (GVD), and it contributes to the value of the product.

A standard SLR project includes the development of a protocol including search strategies, literature search, quality appraisal and documentation of the literature search, data extraction, synthesis, and finally, reporting. Depending on the objectives of the literature review, the search is conducted in three or more databases such as PubMed, Cochrane and EMBASE, and YORK (health economics) or MAUDE (medical device).

The total time spent on the evaluation and selection of the material from the review, is depending on the number of searches and articles. We often assume a maximum of 300 abstracts and 50 full-text articles for review, quality appraisal and data extraction.

Technology Assessments
Before new medicines are to be used, a health economic (HE) evaluation and documentation of the medicine in form of a Single Technology Assessment (STA) is required. In a standard STA project we prepare the reimbursement application for the customer.

The company usually has one or more phase III trials, a Global Value Dossier (GVD), a global health economic model, and some relevant publications. Our job is to adapt this information and gather local data were necessary, to complete an assessment in line with the templet and guidelines by national authorities.

In Norway, the process of writing a STA includes pre-meeting with the Norwegian Medicines Agency (NoMA), general guidance and discussion with the customer, gathering of information on patient flow, clinical practice, comparator, epidemiology, unit cost and consultation with a clinical expert.

In our experience, some health economic models do not contain all the required information needed in order to fulfill the requirements from the national authorities. In these cases, the team will adjust the model with the necessary information, and we may also design models from scratch when necessary.

Primary Sidebar

  • Solutions
    • Early Clinical Development
    • Clinical Development
    • Post-Marketing
  • LINK Advantage – Full Service CRO
  • Market Access & RWE
  • Medical Device
  • Medical Experts
  • Medical Writing
  • PV – Pharmacovigilance Services
  • Clinical Operations
  • Clinical Project Management
  • Quality Assurance Services
  • Regulatory Affairs Services
    • Marketing Compliance
  • Biometrics CRO Services
  • Strategic Advice Group
  • Other Services

Site Footer

Don't miss out on the latest updates

Be the first to hear our breaking news at LINK Medical

  • Home
  • Solutions
  • Therapeutic areas
  • About Us
  • News & Events
  • Contact
  • Careers
  • Search

© 2023 LINK Medical Research
Privacy Policy

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent. Read More
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent1 yearRecords the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_gat_gtag_UA_142237341_11 minuteSet by Google to distinguish users.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
CONSENT2 yearsYouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
nQ_cookieId1 yearAlbacross sets this cookie to help identify companies for better lead generation and more effective ad targeting.
nQ_userVisitId30 minutesNo description available.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
CookieDurationDescription
VISITOR_INFO1_LIVE5 months 27 daysA cookie set by YouTube to measure bandwidth that determines whether the user gets the new or old player interface.
YSCsessionYSC cookie is set by Youtube and is used to track the views of embedded videos on Youtube pages.
yt-remote-connected-devicesneverYouTube sets this cookie to store the video preferences of the user using embedded YouTube video.
yt-remote-device-idneverYouTube sets this cookie to store the video preferences of the user using embedded YouTube video.
SAVE & ACCEPT
Powered by CookieYes Logo